Yep - will be a while, but the potential certainly has been (again) validated with the latest approval.
For all the 'to the moon today' pumpers here - I do not see ANY significant SP movement until the convertible bonds are settled. There's no huge short squeeze on the horizon - SHORTS ARE COVERED BY THE CONVERTS! The 'boom' just ain't gonna happen! (unless we get bought out) So, 24 million shares traded today and yesterday - and we went up, what, 26 cents or so from Friday?
MMM has little to no interest in taking care of shareholders - but you can guarantee that management just scored some nice options with performance bonuses on the approval!
Will take several quarters of solid earnings (showing market acceptance) for any changes to SP and even then we will only hit the $6.81 ceiling. Best of Luck to all!
Sentiment: Strong Buy
Incongruent: " the upside is unlimited once the Cnv bond strangle hold is lifted" and "upside explosion, which could happen at any time"
Bumping this post for those that just don't get it as SP goes from 3.8 to 4.4 to 3.8 in a week
... If you actually believe for a moment that anything material took place on Tuesday to drop market cap of EXEL by 10%, you are in need of a reality check. The stock got played for short-term profit-taking the same as it has for many months. If ever there were a stock screaming to be investigated for dark pool manipulation - it is this one. Tuesday was another Share Price Du Jour, inspired by nothing more than the wash, rinse, repeat cycle that has been endlessly enumerated on this MB ad nauseum.
If Motley had a Fool worth his weight in zit #$%$, this issue would be illuminated for all to ponder.
Rationalize your paper losses however you must, but don't let the Fools fool you...
They don't know squat from shinola.
Another nothing-burger from the fool. Absolutely no mention of the previous predatory financing and converts.
From the article; "Now what: Looking ahead, I think the most important issue for investors to understand is why shorts are piling into this stock. The short thesis, to me, seems to center around the potential commercialization of cabozantinib (brand name: Cometriq) in the second-line kidney cancer setting."
so this stock isn't played like a fiddle? OK, sure. And Hillary will clean up wall street. LOL.
"If that latter is the case, this is a much longer investment than I intended. Is my concern valid?"
MMorrissey has never been an investor-friendly CEO. Never. JMHO GLTA
If you want to get insight on why the latest good news is being traded like a fhaaaart in church, (from a Yahoo MB point of view, FWIW), take a look at these threads:
"Great news but..." Jan 5, 2016
"Whew, 6 million+ shares traded before lunch" Jan 5, 2016
"At this point, what does it matter?" Nov 13, 2015
Search Duckduffer's posts on the CV - he seems to have to best handle on that aspect of why the SP here is a market makers wet dream.
You'll find a lot of frustration from longs - several great posters on the science here - but unless your investing horizon is years, posts on the science and great trial results just, well, at this point, what difference does it make, what does it matter ....
So it's been a week and we are back where you bought (even after one of the most anticipated positive catalysts of the last few months). I trust you did your due diligence before you bought ...... you do realize huge percentage of shorts here are hedged by convertible bonds - so SP goes down, they can make money; SP goes up, they can make money. Ya think there might be some games going on?
Start paddling buddy, this s%!t stream is full of rocks .....
The only post worth reading recently:
"It ain't gonna happen as long as the Cv bond hedge is still in place, these shorts are not naked and are covered by their Cv bonds. Wash, rinse, repeat"
This is why we can't have nice things in our house.
Good point to get out? August. Of 2015. If your time machine is on the fritz, I suggest before the next round of dilutive financing.